TC Medical(SH:600763) Sou Hu Cai Jing·2026-01-13 11:57Group 1 - The core viewpoint of the article highlights the recent performance and financial metrics of Tongce Medical (600763), indicating a slight increase in stock price and mixed capital flow on January 13, 2026 [1] - As of January 13, 2026, Tongce Medical's stock closed at 42.48 yuan, with a trading volume of 15.21 million shares and a total transaction value of 653 million yuan [1] - The capital flow data shows a net outflow of 12.39 million yuan from institutional investors, while retail investors experienced a net outflow of 4.51 million yuan, indicating varied investor sentiment [1] Group 2 - For the first three quarters of 2025, Tongce Medical reported a main revenue of 2.29 billion yuan, reflecting a year-on-year increase of 2.56%, and a net profit attributable to shareholders of 514 million yuan, up 3.16% year-on-year [2] - The third quarter of 2025 saw a single-quarter main revenue of 842 million yuan, with a net profit of 192 million yuan, both showing year-on-year increases of 2.34% and 2.31% respectively [2] - The company has a debt ratio of 25.1%, with investment income of 41.22 million yuan and financial expenses of 31.93 million yuan, alongside a gross profit margin of 41.69% [2] Group 3 - In the last 90 days, seven institutions have provided ratings for Tongce Medical, with four buy ratings and three hold ratings, and the average target price set at 5.29 billion yuan [2]